| abstract |
Described herein are compounds that are useful as protein kinase inhibitors having the formulae I and V: n nor a pharmaceutically acceptable salt thereof, wherein Ring B, Z 1 , Z 2 , U, T, m, n, p, Q, Q′, R 1 , R 2 , R x , R 3 , and R 6 are as defined herein. These compounds, and pharmaceutically acceptable compositions thereof, are useful for treating or lessening the severity of a variety of disorders, including stroke, inflammatory disorders, autoimmune diseases such as SLE lupus and psoriasis, proliferative disorders such as cancer, and conditions associated with organ transplantation. |